Institutional investors hold a majority ownership of BMY through the 74.82% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended September 2015, these large investors purchased a net $9.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WINSLOW CAPITAL MANAGEMENT LLC Bought 9.2 Million shares of Bristol-Myers Squibb
T. ROWE PRICE ASSOCIATES, INC. Bought 8.4 Million shares of Bristol-Myers Squibb
JANUS CAPITAL MANAGEMENT LLC Bought 3.9 Million shares of Bristol-Myers Squibb